Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors

• المؤلفون الرئيسيون: Nunghathai Sawasdee, Methichit Wattanapanitch, Nontaphat Thongsin, Nattaporn Phanthaphol, Chutipa Chiawpanit, Chanitra Thuwajit, Pa Thai Yenchitsomanus, Aussara Panya
• مؤلفون آخرون: Siriraj Hospital
• التنسيق: مقال
• منشور في: 2022
• الموضوعات: Biochemistry, Genetics and Molecular Biology
• الوصول للمادة أونلاين: https://repository.li.mahidol.ac.th/handle/123456789/73408

Breast cancer (BC) is the most common cancer in women. Although standard treatments are successful in patients with BC diagnosed at an early stage, an alternative treatment is required for patients with advanced-stage disease who do not respond to these treatments. The concept of using chemotherapy...